Nuwellis (NUWE) Gains from Investment Securities (2016 - 2026)
Nuwellis (NUWE) posted Gains from Investment Securities of -$26000.0 for Q1 2026, up 18.75% on a QoQ basis from -$32000.0 in Q4 2025, and up 35.0% year-over-year from -$19259.3 in Q1 2025.
Nuwellis (NUWE) Gains from Investment Securities (2016 - 2026) Analysis & Trends
Nuwellis' Gains from Investment Securities history runs 7 years deep, the most recent figure standing at -$26000.0 for Q1 2026.
- Quarterly Gains from Investment Securities rose 35.0% year-over-year to -$26000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.3 million (up 21.15% YoY) and the FY2025 annual result came in at -$4.1 million, up 10.44% from the prior year.
- Gains from Investment Securities was -$26000.0 for Q1 2026 at Nuwellis, up from -$32000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $755000.0 in Q1 2023 and bottomed at -$11.8 million in Q4 2022.
- A 5-year average of -$1.8 million and a median of -$360000.0 in 2024 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities surged 99.14% — and 2025, when it sank 304.04%.
- Nuwellis' Gains from Investment Securities stood at -$11.8 million in 2022, then jumped by 87.21% to -$1.5 million in 2023, then jumped by 99.14% to -$13000.0 in 2024, then slumped by 146.15% to -$32000.0 in 2025, then increased by 18.75% to -$26000.0 in 2026.
- Business Quant data shows NUWE's Gains from Investment Securities at -$26000.0 in Q1 2026, -$32000.0 in Q4 2025, and -$3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn |
| 10 | Nuwellis | 115,014.84 | -1.97 Mn | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26,000.00 |
| Mar 31, 2026 | -26,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Sep 30, 2025 | -3.16 Mn |
| Sep 30, 2025 | -3.16 Mn |
| Jun 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | -3.88 Mn |
| Sep 30, 2024 | -3.88 Mn |
| Jun 30, 2024 | -198,000.00 |
| Jun 30, 2024 | -198,000.00 |
| Mar 31, 2024 | -522,000.00 |
| Mar 31, 2024 | -522,000.00 |
| Dec 31, 2023 | -1.51 Mn |
| Dec 31, 2023 | -1.51 Mn |